Gene Query: ASB9

Dataset Description Geneva Score
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 20.19
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 17.04
Neonatal and adult human testis defined at the single-cell level 15.89
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 15.59
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 10.88
Transcriptional responses of human insulinoma cells to acute cytokine exposure 10.87
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.93
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 8.58
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 8.44
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.73
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.73
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 5.26
Discovering human diabetes-risk gene function with genetics and physiological assays 5.24
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 5.2
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 5.2
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 4.99
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.96
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 4.87
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 4.69
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.63
RNA-seq analyses of human prostate cancer cells 4.58
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.46
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 4.23
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 4.23
Identification of a LIF-responsive replication-competent human β cell 4.16
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 4.13
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 4.12
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.12
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.9
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 3.75
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.67
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.63
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.63
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.63
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 3.54
Overexpression and knockdown experiment for circCSNK1G3 3.49
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.45
MYCi361 regulates MYC target genes 3.38
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.29
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.27
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.16
The Human Testis Cell Atlas via Single-cell RNA-seq 3.04
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.83
Accurate annotation of human protein-coding small open reading frames 2.74
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 2.69
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.6
TGF-β promotes genomic instability after loss of RUNX3 2.59
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 2.55
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 2.55
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.54
METTL3 promotes translation in human cancer cells 2.49
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.39
The regulartory role of ZCCHC24 in splicing machinery 2.37
Dtx3L and Androgen Signaling in Prostate Cancer 2.35
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 2.27
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 2.27
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.27
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.25
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.25
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.24
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.22
Genome-wide analysis of the Integrator complex (HTS) 2.22
Genome-wide analysis of the Integrator complex 2.22
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.21
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.2
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.2
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.18
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.1
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.1
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 2.03
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 2.01
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.99
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 1.98
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.95
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.95
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.92
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 1.9
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.85
Nutritional control of protein translation 1.83
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.76
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 1.76
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 1.76
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.74
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 1.7
Nrf2 regulated genes in A549 cells 1.69
Identification of Nrf2 regulated genes by RNA sequencing 1.69
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 1.65
NHLRC1 re-expression in cancer cells 1.61
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.61
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.59
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 1.59
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.55
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.53
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.52
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.51
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 1.51
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.49
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.49
Transcriptome analyses of human pancreatic islets and pseudoislets 1.48
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 1.39
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.37
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.33
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 1.32
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.27
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.23
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.22
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.22
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 1.22
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.21
A prostate cancer chromatin interaction map 1.2
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.18
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.16
STX4 Over-Expression in Human islets 1.14
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 1.13
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 1.13
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.12
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 1.11
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 1.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.1
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.1
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.1
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.09
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.09
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.07
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.07
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 1.07
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 1.05
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.04
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.03
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 1.0
hnRNP C is a key regulator of protein synthesis in mitosis 1.0
Identification of long noncoding RNAs in T-ALL cell lines 0.98
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 0.95
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.95
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.95
Gene expression profile difference among renal location in a stone former 0.94
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 0.93
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.93
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 0.93
The conserved transcriptional landscapes in human spermatogenesis 0.92
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 0.92
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 0.92
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 0.91
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.9
Effect of Influenza virus infection on lncRNA expression in A549 cells 0.89
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.89
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.89
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.88
Control of prostate tumour growth by the long non-coding RNA GHSROS 0.88
Gene expression analysis of the impact of TDP-43 knockout in human cells. 0.86
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.85
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.84
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.84
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.84
Expression data from miR340 overexpressing human A549 cells 0.83
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 0.82
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.81
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 0.81
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.8
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.8
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.79
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.79
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 0.78
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.78
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 0.78
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 0.77
Differentially expressed genes post knock down of lincDUSP26 0.77
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.76
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.76
Cellular response to hepatitis E virus (HEV) infection 0.75
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.74
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.74
Effect of drugs on transcriptomic profiles 0.74
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 0.73
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.72
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.72
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 0.71
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 0.71
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 0.71
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 0.71
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.71
N6-methyladenine DNA Modification in Glioblastoma 0.71
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.69
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 0.69
Effect of Hotair overexpression in human breast cancer cell lines 0.68
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 0.67
Non-coding regions are the main source of tumor-specific antigens 0.67
Non-coding regions are the main source of tumor-specific antigens [human] 0.67
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.67
Evaluating pre-clinical models for studying NASH driven HCC. 0.66
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 0.66
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 0.66
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 0.65
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 0.65
Hepatitis C virus functionally sequesters miR-122 0.65
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.64
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.64
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 0.64
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.64
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.64
Gene expression analysis of dengue-infected cells 0.63
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.63
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.63
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.63
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.62
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.61
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.61
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.61
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 0.61
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 0.61
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 0.61
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.6
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.6
Dermal endothelial cells of type 2 diabetic patients 0.6
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 0.6
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 0.6
BASP1 modifies the Tamoxifen response 0.59
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.57
Genes significantly down or Up-regulated upon RNF219 knockdown 0.57
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 0.56
Genome-wide analysis of Dengue virus 2 infected cells 0.56
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.56
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.56
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.55
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 0.55
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 0.55
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 0.55
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.55
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 0.55
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 0.54
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 0.54
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 0.54
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.53
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.52
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.52
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.52
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 0.52
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.51
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.51
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.51
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 0.51
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.51
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 0.51
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 0.51
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 0.5
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 0.5
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.5
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.49
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 0.49
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 0.49
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.49
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 0.49
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 0.48
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.47
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.47
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 0.47
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 0.47
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.47
Differential gene expression of human melanoma cells [RNA-seq] 0.47
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 0.47
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.47
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.46
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.46
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.46
MYCi975 regulates MYC target genes 0.46
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.45
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.45
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 0.45
A Unique Epigenomic Landscape Defines Human Erythropoiesis 0.45
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 0.45
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.45
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.44
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 0.44
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 0.44
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.43
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.43
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 0.43
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.43
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 0.43
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 0.43
The role of FAM46C in myeloma cells 0.43
The role of FAM46C in myeloma cells [sequencing] 0.43
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.43
MOF acetyl transferase regulates transcription and respiration in mitochondria 0.43
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 0.42
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.42
Interaction between mitoNEET and NAF-1 in cancer cells 0.42
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.42
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.42
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 0.42
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.42
Investigate A2M treatment on human prostate cancer xenograft in mice 0.42
Investigate A2M treatment on human prostate cancer and mouse liver 0.42
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.41
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.41
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.41
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 0.41
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.41
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.4
Single-Cell Genotyping of Transcriptomes 0.4
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.4
SF3B1 Degron knockdown RNA-seq 0.4
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.4
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.39
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.39
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.38
CD86 regulates a pro-survival signal in myeloma cells 0.38
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.38
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.38
mRNA recovered upon RNF219 IP. [RNA-IP] 0.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.38
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.37
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.37
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.36
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.36
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.36
Gene expression profile in breast cancer cell lines using RNA sequencing 0.36
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.35
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.35
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.35
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.35
Universal alternative splicing of noncoding exons 0.35
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.34
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.34
Human islets of varying quality: the good, the (not so) bad and the ugly 0.34
Exploring ILF2 regulatory genes by next-generation sequencing 0.33
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 0.33
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 0.33
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.32
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.32
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.32
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.32
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.32
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.31
The DNA methylation landscape of human melanoma 0.31
The DNA methylation landscape of human melanoma [RNA-Seq] 0.31
RNAseq of T-ALL upon long non coding rna purturbation 0.31
RNAseq Study in CC-671 Treated Cal-51 Cells 0.3
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.3
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.3
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.3
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.3
Finding missing proteins from epigenetically manipulated human cells 0.3
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.3
Dynamic 3D chromosomal landscapes in acute leukemia 0.3
RNA-seq of tumor cells following angiopellosis extravasation 0.3
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 0.3
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.3
Effect of FGF13 depletion on the H460 cell line 0.3
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.29
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.29
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.29
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.29
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 0.28
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 0.28
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.28
Genome-wide discovery of human splicing branchpoints [RNAse] 0.28
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.27
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.27
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.27
The role of CFTR in islet function 0.26
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.26
Genome-wide discovery of human splicing branchpoints 0.25
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.25
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 0.24
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.24
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.24
JAK dependent survival of ALK- ALCL 0.23
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.22
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.22
Bone marrow derived human B cells [normal proB] 0.22
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.22
Transcriptome analysis of BAP1 knockout and restoration 0.22
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.21
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.21
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 0.21
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.21
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.21
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.2
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.2
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 0.2
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 0.2
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 0.2
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.2
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.19
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.19
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.19
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.19
RNA-Seq with and without RNase treatment in PCa cell lines 0.18
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.18
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.18
m6A-dependent regulation of messenger RNA stability 0.18
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.18
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.18
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.18
Patient-derived xenograft platform for metastatic melanoma 0.17
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.17
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.16
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.16
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.16
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.16
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.16
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 0.15
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 0.15
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.15
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.15
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.15
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.15
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.15
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.14
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.14
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.14
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.14
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.14
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.13
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.13
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 0.13
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.13
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.13
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.13
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.12
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.12
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.12
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.12
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.12
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.12
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.12
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.12
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.12
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.11
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.11
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.1
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.1
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.1
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.1
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.09
Energy Metabolism during Anchorage-Independence 0.09
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.09
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.09
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.09
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.08
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.08
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.08
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.08
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.08
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.07
Enhancer activation during EGF response 0.07
Leucegene: ALL sequencing 0.07
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.07
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.07
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.07
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.07
RNA seq_PDX2_SHP099 0.07
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.07
Paxillin regulates genomic networks in prostate cancer [PC3] 0.06
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.06
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.05
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 0.05
Gene expression changes due to PARP knockdown in human cells 0.05
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.05
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.05
Single-cell analysis of adult human ovary using 10X genomics 0.05
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.05
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.04
The transcriptome and chromatin accessbility landscape of mammalian germline 0.04
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.04
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.04
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 0.04
Genome wide miR-191 target profile determined by RIP and gene expression profiling 0.04
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.04
Gene expression analysis in response to hypoxic pathway inhibition 0.04
Analyses of T-ALL (COG study) 0.04
RNA sequencing of T-ALL (COG study) 0.04
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.04
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.04
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.04
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.04
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.03
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.03
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.03
Regulation of hypoxia-inducible factor activity by ZMYND8 0.03
Transcriptome-wide modulation of splicing by the exon junction complex 0.03
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.02
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.02
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.02
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.01
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.01
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.01
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.0
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.0
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation